🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Marker Therapeutics, Inc.

Marker Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Multi TAA-specific T cell technology

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing T cell-based immunotherapies and peptide-based vaccines for treating hematological malignancies and solid tumors in the US.

Tags: T cell therapy, cancer treatment, hematological malignancies, immuno-oncology, solid tumors, vaccines

Website

Contact | About | Management | Directors | About | Contact | Contact | Careers | About | About

Symbol: MRKR

Recent Price: $3.34

Industry: Biotechnology

CEO: Dr. Juan F. Vera M.D.

Sector: Healthcare

Employees: 8

Address: 3200 Southwest Freeway, Houston, TX 77027

Phone: 713 400 6400

Leadership

  • David Eansor, President, Protein Sciences Segment, Bio-Techne Corporation
  • Steve Elms, Managing Partner, Aisling Capital
  • John R. Wilson, CEO, Wilson Wolf Manufacturing, Co-Founder Marker Therapeutics, Co-Founder AlloVir
  • Juan F. Vera, Chief Executive Officer & Co-Founder, Marker Therapeutics, Co-Founder, AlloVir
  • Katharine Knobil, M.D., Chief Medical Officer at Agilent Technologies, Inc.

Last updated: 2024-12-31